Allen & Overy (A&O) and Ashurst are advising on United Business Media’s (UBM’s) € 282.5m (£188m) acquisition of parts of the drug information business of MediMedia.

A&O is advising UBM, while Ashurst – another of UBM’s corporate advisers – is advising MediMedia, which it has worked with since its formation in 2002, when it was separated from Vivendi.